April 19th 2021February 11th 2021 Diversity & inclusion in Pharma Read more at: https://www.pharmexec.com/view/diversity-inclusion-in-pharma-industry-leaders-bring-conversation-to-forefront
Our CEO spoke at the LSX World Congress USA in BostonJune 21st 2022Read More Our CEO spoke at the LSX World Congress USA in Boston
Shorla Oncology at ASCO Annual Meeting, Chicago 2022May 30th 2022Read More Shorla Oncology at ASCO Annual Meeting, Chicago 2022
Our CEO on Biocentury’s Bio€quity Europe podcastMay 18th 2022Read More Our CEO on Biocentury’s Bio€quity Europe podcast
Our CCO, Nicholas Holsman speaks at the MassBio ConferenceMay 5th 2022Read More Our CCO, Nicholas Holsman speaks at the MassBio Conference
Shorla Oncology Appoints Dennis Purcell as ChairmanMarch 29th 2022Read More Shorla Oncology Appoints Dennis Purcell as Chairman
Company Name Change: Shorla Pharma is now Shorla Oncology!March 10th 2022Read More Company Name Change: Shorla Pharma is now Shorla Oncology!
Shorla Oncology at Bio CEO & Investor conference, New York 2022February 14th 2022Read More Shorla Oncology at Bio CEO & Investor conference, New York 2022
Shorla Oncology at Euronext IPO ready programme, Dublin 2022February 14th 2022Read More Shorla Oncology at Euronext IPO ready programme, Dublin 2022
3 Keys To A Successful Biotech LaunchFebruary 1st 2022Read More 3 Keys To A Successful Biotech Launch
